Is Second Knee at Risk During Simultaneous Bilateral Total Knee Arthroplasty.
1 other identifier
interventional
163
0 countries
N/A
Brief Summary
The effects of single-team simultaneous bilateral total knee arthroplasty on peri- and postoperative complications are clear. The investigators hypothesized that second knee at risk during single-team simultaneous bilateral total knee arthroplasty and have more early postoperative complication rates than the first knee. Therefore, this prospective study compared minor and major local complications for 90 days postoperatively between the first and second during knee single-team simultaneous bilateral total knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2020
CompletedFirst Posted
Study publicly available on registry
April 29, 2020
CompletedStudy Start
First participant enrolled
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedApril 30, 2020
April 1, 2020
1 year
April 25, 2020
April 29, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Local complications
Local operation related complications rate
90 days
Study Arms (2)
First Knee
ACTIVE COMPARATORThe first knee is the knee where the surgery will begin to be applied.
Second Knee
EXPERIMENTALThe second knee is the knee where the surgeon will apply secondly.
Interventions
Eligibility Criteria
You may qualify if:
- Primary bilateral knee osteoarthritis with refractory to conservative treatment
- Patients who accept participation in the research and the randomization
You may not qualify if:
- no history of malignancy
- less than 75 years old
- severe cardiac insufficiency and morbid obesity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Residents Doctor in Orthopedics Department, Principal Investigator
Study Record Dates
First Submitted
April 25, 2020
First Posted
April 29, 2020
Study Start
May 15, 2020
Primary Completion
May 15, 2021
Study Completion
June 30, 2021
Last Updated
April 30, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR